NCT04724330

Brief Summary

Healthy for Two, Healthy for You (H42/H4U) is an innovative evidence-based pregnancy/postpartum health coach intervention that is remotely-delivered (phone coaching using motivational interviewing, web-based platform, mobile phone behavioral tracking). The aim of this randomized controlled trial (RCT) is to embed H42/H4U into Johns Hopkins prenatal care clinics that serve a racially and economically diverse population, leveraging existing staff as trained health coaches to test its effectiveness and implementation. The investigators hypothesize that women in the H42/H4U arm will have lower gestational weight gain and lower rates of gestational diabetes, without an increase in low birth weight infants, and that implementation into the investigators' prenatal care clinics will be feasible and scalable.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
534

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 26, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

March 15, 2021

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2025

Completed
Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

3.9 years

First QC Date

January 22, 2021

Last Update Submit

September 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total gestational weight gain

    Difference between weight (lbs) at 37 weeks and baseline first trimester weight, measured prior to 15 weeks gestation.

    At 37 weeks in pregnancy

Secondary Outcomes (5)

  • Number of participants who gained excess weight

    At 37 weeks in pregnancy

  • Incidence of gestational diabetes mellitus

    At 37 weeks in pregnancy

  • Postpartum weight retention

    6 months after delivery

  • Infant weight

    At 6 months of age

  • Proportion of low birth weight infants

    At time of birth/delivery

Study Arms (2)

Healthy for Two/Healthy for You (H42/H4U)

EXPERIMENTAL

Those assigned to the intervention group will receive the H42/H4U health coaching intervention during pregnancy and 12 weeks postpartum.

Behavioral: Healthy for Two/Healthy for You

Usual Care Comparison Group: Maintain Health in Pregnancy (mHIP)

NO INTERVENTION

Those assigned to the Usual Care comparison group, mHIP, will receive typical, evidence- and guideline-based experience in the prenatal care clinics.

Interventions

\~10 month (early pregnancy to 12 weeks postpartum), remotely-delivered, behavioral lifestyle intervention including health coach contacts (via phone, videoconference, and email/MyChart) and an interactive web-based platform.

Also known as: H42/H4U
Healthy for Two/Healthy for You (H42/H4U)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥18
  • Singleton pregnancy
  • ≤15 weeks gestation with documented prenatal weight and height in electronic health record
  • Body mass index ≥ 25.0 kg/m2
  • English-speaking
  • Has smartphone, laptop or tablet and willing to use it for this study
  • Has email address and willing to use for this study

You may not qualify if:

  • BMI \<25 kg/m2
  • Multiple fetuses
  • History of pre-gestational Type 1 or Type 2 diabetes or taking diabetes medication for treatment of diabetes prior to first prenatal visit
  • Prior history of severe preeclampsia, pre-term birth (\< 32 weeks gestation)
  • Poorly controlled blood pressure (\> 160/100 mmHg)
  • Substance use disorder or positive urine toxicology (except for THC) for illicit substances (screening done as part of routine care)
  • Psychiatric hospitalization in last 12 months or diagnosis of severe mental illness that is not well controlled
  • Active diagnosis of an eating disorder
  • Unable to walk 1 block without pain or shortness of breath
  • No email address
  • Unable to speak or read in English
  • Planning to move in next 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Health System and University

Baltimore, Maryland, 21205, United States

Location

Related Publications (2)

  • Drabo EF, McKinney CD, Martin LM, Nair D, Coughlin JW, Chen T, Borahay MA, Wang NY, Bennett WL. Protocol for the economic evaluation of the "Healthy for Two/Healthy for You" pragmatic lifestyle intervention in prenatal care to reduce gestational weight gain and gestational diabetes mellitus. Contemp Clin Trials. 2025 Sep;156:108037. doi: 10.1016/j.cct.2025.108037. Epub 2025 Jul 31.

  • Bennett WL, Coughlin JW, Henderson J, Martin S, Yazdy GM, Drabo EF, Showell NN, McKinney C, Martin L, Dalcin A, Sanders R, Wang NY. Healthy for Two/Healthy for You: Design and methods for a pragmatic randomized clinical trial to limit gestational weight gain and prevent obesity in the prenatal care setting. Contemp Clin Trials. 2022 Feb;113:106647. doi: 10.1016/j.cct.2021.106647. Epub 2021 Dec 8.

MeSH Terms

Conditions

Gestational Weight GainPediatric ObesityDiabetes, GestationalOverweightObesity

Condition Hierarchy (Ancestors)

Weight GainBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Officials

  • Wendy L Bennett, MD, MPH

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2021

First Posted

January 26, 2021

Study Start

March 15, 2021

Primary Completion

January 31, 2025

Study Completion

June 25, 2025

Last Updated

September 10, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations